Drugs / PRAM9
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04074317 | Aug 2019 → Apr 2020 | type 1 diabetes mellitus | Xeris Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRAM9 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04074317 ↗ |
| Route | Subcutaneous | “SC injection” NCT04074317 ↗ |